Director/PDMR Shareholding

Drax Group PLC
26 September 2023
 

26 September 2023

 

Drax Group plc

("Drax" or "the Company")

 

Symbol: DRX

 

Notification of Transactions of Directors,

Persons Discharging Managerial Responsibility or Connected Persons

 

 

Andy Skelton, an Executive Director and PDMR, has notified the Company that on 25 September 2023 he purchased a total of 11,178 ordinary shares of 11 16/29 pence each in the Company. This comprised two trades being 9,202 ordinary shares at an aggregate price of 454.1 pence per share and 1,976 ordinary shares at an aggregate price of 452.928 pence per share. Following the transaction, Mr Skelton's total shareholding in the Company is 464,811 ordinary shares.

 

The information below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

 

Details of PDMR / person closely associated with them ("PCA")

Name

Andy Skelton

Reason for the notification

Position / status

Chief Financial Officer

Initial notification / amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Drax Group plc

LEI

549300YPSNTXR4ZHSR98

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

Identification code

Ordinary shares of 11 16/29 pence

GB00B1VNSX38

Nature of the transaction

Purchase of ordinary shares

Price(s) and volume(s)

Price(s)

Volume(s)

454.100 pence per share

 

452.928 pence per share

9,202

 

 

1,976

Aggregated information

-     Aggregated volume

-     Price

 

11,178

453.893 pence per share

Date of the transaction

25 September 2023

Place of the transaction

XLON

 

 

--ENDS--

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Drax Group (DRX)
UK 100

Latest directors dealings